Non-invasive
No sedation or invasive procedures required
Simple, non-invasive Colorectal Cancer screening.
Simple, non-invasive Colorectal Cancer screening.
At-home using a swallowable capsule that directly examines the colon—without colonoscopy.
Connect
•
Detect
•
Protect
What is Peek
A new approach to Colorectal Screening.
A new approach to Colorectal Screening.
Peek is a swallowable capsule designed to screen the colon for pre-cancerous polyps and early cancer. Instead of relying on indirect tests or invasive procedures, Peek directly examines the colon in a simple, user-friendly way.
Peek is a swallowable capsule designed to screen the colon for pre-cancerous polyps and early cancer. Instead of relying on indirect tests or invasive procedures, Peek directly examines the colon in a simple, user-friendly way.
AI
Peek App
You
Peek Capsule
Peek AI Cloud
Review Platform
Clinical Experts
The Peek Platform
AI
Peek App
You
Peek Capsule
Peek AI Cloud
Review Platform
Clinical Experts
The Peek Platform
The Peek Platform
AI
Clinical Experts
Peek Capsule
Peek App
Peek AI Cloud
Review Platform
You
Simple Guided Process
Simple, at-home screening
Simple, at-home screening
Everything you need to get started with Peek, step by step.
Everything you need to get started with Peek, step by step.
Download the App
1
Prepare Your Bowel
2
Swallow the capsule
3
Continue your day
4
Download the App
1
Prepare Your Bowel
2
Swallow the capsule
3
Continue your day
4
Download the App
1
Prepare Your Bowel
2
Swallow the capsule
3
Continue your day
4
Once the procedure is complete, the device is naturally excreted and can be safely flushed down the toilet, with no retrieval required.
Once the procedure is complete, the device is naturally excreted and can be safely flushed down the toilet, with no retrieval required.
How Peek works?
Peek in action
Peek in action
The user swallows a small capsule that travels naturally through the gastrointestinal tract. The capsule captures internal images and data which are securely transmitted to a smartphone via the Peek app and reviewed by clinicians using AI-assisted tools.
The user swallows a small capsule that travels naturally through the gastrointestinal tract. The capsule captures internal images and data which are securely transmitted to a smartphone via the Peek app and reviewed by clinicians using AI-assisted tools.
Words from Experts
“As an oncologist, I have witnessed firsthand the challenges that patients with colorectal cancer face, including the physical, emotional, and financial burdens of treatment. Equitable Technologies’ innovative approach offers significant promise in mitigating these challenges through early detection of pre-cancerous polyps.”
Dr. Ramesh Shivdasani
Professor of Medicine, Harvard Medical School Deputy Director GI oncology
Dana-Farber Cancer Institute
“As an oncologist, I have witnessed firsthand the challenges that patients with colorectal cancer face, including the physical, emotional, and financial burdens of treatment. Equitable Technologies’ innovative approach offers significant promise in mitigating these challenges through early detection of pre-cancerous polyps.”
Dr. Ramesh Shivdasani
Professor of Medicine, Harvard Medical School Deputy Director GI oncology
Dana-Farber Cancer Institute
“ By providing a less invasive and more patient-friendly screening option, the PEEK capsule has the potential to increase adherence to regular screening, ultimately benefiting patients. Moreover, this approach could enable the healthcare system to allocate more resources toward therapeutic colonoscopies, where they are most needed.”
Dr. Tolga Erim
Division Chair for Gastroenterology, Hepatology and Nutrition
Cleveland Clinic in Florida
“ By providing a less invasive and more patient-friendly screening option, the PEEK capsule has the potential to increase adherence to regular screening, ultimately benefiting patients. Moreover, this approach could enable the healthcare system to allocate more resources toward therapeutic colonoscopies, where they are most needed.”
Dr. Tolga Erim
Division Chair for Gastroenterology, Hepatology and Nutrition
Cleveland Clinic in Florida
“ By providing a less invasive and more patient-friendly screening option, the PEEK capsule has the potential to increase adherence to regular screening, ultimately benefiting patients. Moreover, this approach could enable the healthcare system to allocate more resources toward therapeutic colonoscopies, where they are most needed.”
Dr. Tolga Erim
Division Chair for Gastroenterology, Hepatology and Nutrition Cleveland Clinic in Florida
Cleveland Clinic in Florida
“As someone with deep regulatory experience in gastrointestinal devices, I recognize the potential for PEEK to significantly shift the CRC screening paradigm. Importantly, its patient-friendly design - minimizing procedural burden and enabling home-based testing - has the potential to improve screening uptakes and reduce disparities in access, especially amid the ongoing shortage of practicing gastroenterologists.”
Dr. Herbert Lerner
Former Deputy Director, Division of Reproductive, Gastro-Renal, and Urological Devices
US FDA
“As someone with deep regulatory experience in gastrointestinal devices, I recognize the potential for PEEK to significantly shift the CRC screening paradigm. Importantly, its patient-friendly design - minimizing procedural burden and enabling home-based testing - has the potential to improve screening uptakes and reduce disparities in access, especially amid the ongoing shortage of practicing gastroenterologists.”
Dr. Herbert Lerner
Former Deputy Director, Division of Reproductive, Gastro-Renal, and Urological Devices
US FDA
“As someone with deep regulatory experience in gastrointestinal devices, I recognize the potential for PEEK to significantly shift the CRC screening paradigm. Importantly, its patient-friendly design - minimizing procedural burden and enabling home-based testing - has the potential to improve screening uptakes and reduce disparities in access, especially amid the ongoing shortage of practicing gastroenterologists.”
Dr. Herbert Lerner
Former Deputy Director, Division of Reproductive, Gastro-Renal, and Urological Devices
US FDA
Why it needs to change?
Colorectal cancer is preventable -
but screening is failing.
Colorectal cancer is preventable -
but screening is failing.
Colorectal cancer is one of the leading causes of cancer related deaths globally. However, millions remain unscreened due to cost, invasiveness, and limited access.
Colorectal cancer is one of the leading causes of cancer related deaths globally. However, millions remain unscreened due to cost, invasiveness, and limited access.
CRC is 2nd most common cancer globally
CRC is 2nd most common cancer globally
New cases in 2025
New cases in 2025
Every 30 Seconds
Every 30 Seconds
CRC takes a life
CRC takes a life
4 in 5 people
4 in 5 People
4 in 5 people
have never been screened
have never been screened
have never been screened
98.5%
98.5%
Increase in cases for age below 45 year olds
Increase in cases for age below 45 year olds
63%
63%
(annual increases in new cases by 2040)
annual increases in new cases by 2040
(annual increases in new cases by 2040)
Problem Statement
Detect disease before it progresses.
Detect disease before it progresses.
Colorectal cancer develops over time, often starting as small, pre-cancerous polyps. Stool and DNA based stool or blood tests miss pre-cancerous polyps—the stage where intervention is most effective.
Colorectal cancer develops over time, often starting as small, pre-cancerous polyps.
Stool and DNA based stool or blood tests miss pre-cancerous polyps—the stage where intervention is most effective.
Colorectal cancer develops over time, often starting as small, pre-cancerous polyps. Stool and DNA based stool or blood tests miss pre-cancerous polyps—the stage where intervention is most effective.
Pre-cancerous
Cancerous
Severe
Impact on Lifestyle
15%
5 year survival rate
$100K-$200K
Treatment Cost
~1-2 years
Treatment Duration
Hyperproliferation
Adenomatous polyps (Small)
Adenomatous polyps (Large)
Severe dysplasia
Adenocarcinoma
Invasive Cancer
Severe
Impact on Lifestyle
15%
5 year survival rate
$100K-$200K
Treatment Cost
~1-2 years
Treatment Duration
Hyperproliferation
Adenomatous polyps (Small)
Adenomatous polyps (Large)
Severe dysplasia
Adenocarcinoma
Invasive Cancer
Cancerous
Pre-cancerous
Cancerous
Severe
Impact on Lifestyle
15%
5 year survival rate
$100K-$200K
Treatment Cost
~1-2 years
Treatment Duration
Hyperproliferation
Adenomatous polyps (Small)
Adenomatous polyps (Large)
Severe dysplasia
Adenocarcinoma
Invasive Cancer
Why choose us
Designed to combine the strengths of existing methods.
Designed to combine the strengths of existing methods.
Peek is designed to expand access to
effective screening, without traditional barriers.
Peek is designed to expand access to
effective screening, without traditional barriers.
Peek
Stool tests
DNA Stool tests
Colonoscopy
Key features
Direct visualization of Colon
Accuracy for pre-cancerous polyp detection
Non-invasive procedure
No sedation required
At-home or outpatient workflow
Scalable screening model
Peek
Stool tests
DNA Stool tests
Colonoscopy
Key features
Direct visualization of the colon
Direct visualization of the colon
Accuracy for pre-cancerous polyp detection
Non-invasive procedure
No sedation required
At-home or outpatient workflow
Scalable screening model
Non-invasive
No sedation or invasive procedures required
User-friendly
Simple ingestion-based workflow
User-friendly
Simple ingestion-based workflow
Actionable
Provides visual data for clinicians review
Actionable
Provides visual data for clinicians review
Scalable
Designed for population-level screening programs
Scalable
Designed for population-level screening programs
FAQs
Have Questions?
Have Questions?
General
How it works
Prep & Comfort
Tech & Privacy
Clinical
01
What is Peek?
Peek is a swallowable capsule designed to screen the colon for precancerous polyps and early colorectal cancer. It captures data from inside the body, which is analyzed and reviewed by a clinician.
02
Who is Peek for?
03
Is Peek a replacement for colonoscopy?
General
How it works
Prep & Comfort
Tech & Privacy
Clinical
01
What is Peek?
Peek is a swallowable capsule designed to screen the colon for pre-cancerous polyps and early colorectal cancer. It captures data from inside the body, which is analyzed and reviewed by a clinician.
02
Who is Peek for?
03
Is Peek a replacement for colonoscopy?
A new standard for colorectal screening
A new standard for colorectal screening
Be among the first to access Peek.
Be among the first to access Peek.
Contact Information
USA (HQ)
Boston
Malaysia
Kuala Lumpur
India
Hyderabad
Email Address
contact@screenwithpeek.com
©
2026
Equitable Technologies Inc. All rights reserved.
Our Offices
Boston (HQ)
Kuala Lumpur
Hyderabad
Email Address:
contact@screenwithpeek.com
©
2026